Improving HIV prevention and treatment for people who inject drugs.
Impact of a novel HIV peer navigationand overdose prevention intervention on engagement in the HIV prevention and treatment cascade.
This study is testing a mobile health van that brings HIV prevention and treatment services right to people who inject drugs, helping them learn about and access important resources like PrEP, peer support, and drug safety information, especially during tough times like the opioid crisis and the COVID-19 pandemic.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10868454 on NIH RePORTER |
What this research studies
This research focuses on enhancing HIV prevention and treatment for individuals who inject drugs (PWID) by implementing a mobile health van that offers on-site pre-exposure prophylaxis (PrEP), peer navigation, and drug checking services. The study aims to increase awareness and engagement in PrEP among PWID, who are at high risk for HIV, particularly in the context of the ongoing opioid epidemic and the disruptions caused by the COVID-19 pandemic. By integrating peer support and drug safety information, the project seeks to address the complex needs of this population and improve their access to essential health services.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who inject drugs and are at risk for HIV infection.
Not a fit: Patients who do not inject drugs or are not at risk for HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase the uptake of HIV prevention measures among people who inject drugs, ultimately reducing HIV transmission rates.
How similar studies have performed: Other research has shown success in using mobile health interventions and peer navigation to improve health outcomes in similar high-risk populations.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Sherman, Susan G. — Johns Hopkins University
- Study coordinator: Sherman, Susan G.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.